메뉴 건너뛰기




Volumn 66, Issue 6, 2014, Pages 1148-1156

Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancer

Author keywords

Bladder cancer; EORTC questionnaire; Quality of life; Validation

Indexed keywords

BCG VACCINE; CELECOXIB; MITOMYCIN; PLACEBO; CYCLOOXYGENASE 2 INHIBITOR;

EID: 84909946642     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.02.034     Document Type: Article
Times cited : (69)

References (16)
  • 1
    • 84880324406 scopus 로고    scopus 로고
    • Cancer Research UK Web site. Accessed September 2013
    • Bladder cancer incidence statistics. Cancer Research UK Web site. http://info.cancerresearchuk.org/cancerstats/types/bladder/incidence/. Accessed September 2013.
    • Bladder Cancer Incidence Statistics
  • 3
    • 0027417437 scopus 로고
    • The European Organization for Research and Treatment of Cancer QLQ-C30: A quality of life instrument for use in international clinical trials in oncology
    • N.K. Aaronson, S. Ahmedzai, and B. Bergman The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376
    • (1993) J Natl Cancer Inst , vol.85 , pp. 365-376
    • Aaronson, N.K.1    Ahmedzai, S.2    Bergman, B.3
  • 5
    • 0027407786 scopus 로고
    • The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure
    • D.F. Cella, D.S. Tulsky, and G. Gray The Functional Assessment of Cancer Therapy scale: development and validation of the general measure J Clin Oncol 11 1993 570 579
    • (1993) J Clin Oncol , vol.11 , pp. 570-579
    • Cella, D.F.1    Tulsky, D.S.2    Gray, G.3
  • 14
    • 84874371892 scopus 로고    scopus 로고
    • Reporting of patient-reported outcomes in randomized trials: The CONSORT PRO extension
    • CONSORT PRO Group
    • M. Calvert, J. Blazeby, D.G. Altman, D.A. Revicki, D. Moher, M.D. Brundage CONSORT PRO Group Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension JAMA 309 2013 814 822
    • (2013) JAMA , vol.309 , pp. 814-822
    • Calvert, M.1    Blazeby, J.2    Altman, D.G.3    Revicki, D.A.4    Moher, D.5    Brundage, M.D.6
  • 15
    • 15044340558 scopus 로고    scopus 로고
    • Health related quality of life after radical cystectomy and urinary diversion for bladder cancer: A systematic review and critical analysis of the literature
    • M.P. Porter, and D.F. Penson Health related quality of life after radical cystectomy and urinary diversion for bladder cancer: a systematic review and critical analysis of the literature J Urol 173 2005 1318 1322
    • (2005) J Urol , vol.173 , pp. 1318-1322
    • Porter, M.P.1    Penson, D.F.2
  • 16
    • 80053918672 scopus 로고    scopus 로고
    • A randomised controlled trial of celecoxib to prevent recurrence of non-muscle invasive bladder cancer
    • A.L. Sabichi, J. Lee, and B. Grossman A randomised controlled trial of celecoxib to prevent recurrence of non-muscle invasive bladder cancer Cancer Prev Res 4 2011 1580 1589
    • (2011) Cancer Prev Res , vol.4 , pp. 1580-1589
    • Sabichi, A.L.1    Lee, J.2    Grossman, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.